Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSKP.L Regulatory News (SKP)

  • There is currently no data for SKP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - Skyepharma Plc

29 Apr 2016 10:39

RNS Number : 8249W
Nplus1 Singer Capital Markets Ltd
29 April 2016
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Nplus1 Singer Capital Markets Limited

 

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

 

Skyepharma Plc

 

(c) Name of the party to the offer with which exempt principal trader is connected:

 

Skyepharma Plc

 

(d) Date dealing undertaken:

28 April 2016

 

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

Yes

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ Sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

ORD 100P

 

Purchase

 

222

 

479.7625p

 

479.7625p

 

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

Date of disclosure:

29 April 2016

Contact name:

Kelly Morgan

Telephone number:

020 7496 3094

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FERLIFVASTIAFIR
Date   Source Headline
31st May 20131:01 pmRNSHolding(s) in Company
21st May 20134:49 pmRNSHolding(s) in Company
21st May 20131:52 pmRNSHolding(s) in Company
21st May 201310:13 amRNSHolding(s) in Company
14th May 201312:35 pmRNSHolding(s) in Company
13th May 20137:00 amRNSBREO ELLIPTA Receives Regulatory Approval in U.S.
9th May 20131:08 pmRNSResult of AGM
9th May 20137:00 amRNSInterim Management Statement
3rd May 201311:31 amRNSDirector/PDMR Shareholding
11th Apr 20134:24 pmRNSAnnual Financial Report
5th Apr 20133:34 pmRNSDirector/PDMR Shareholding
3rd Apr 20133:06 pmRNSDirector/PDMR Shareholding
28th Mar 20133:47 pmRNSDirector/PDMR Shareholding
26th Mar 20132:06 pmRNSHolding(s) in Company
21st Mar 20137:00 amRNSFinal Results
18th Mar 201312:37 pmRNSHolding(s) in Company
15th Mar 20139:41 amRNSHolding(s) in Company
6th Mar 201311:41 amRNSDirector/PDMR Shareholding
5th Mar 201310:55 amRNSNotice of Results
13th Feb 20139:47 amRNSDirector/PDMR Shareholding
6th Feb 20134:58 pmRNSDirector/PDMR Shareholding
5th Feb 201310:23 amRNSHolding(s) in Company
8th Jan 20132:50 pmRNSHolding(s) in Company
4th Jan 20134:03 pmRNSDirector/PDMR Shareholding
21st Dec 20124:23 pmRNSDirector/PDMR Shareholding
21st Dec 20124:22 pmRNSDirector/PDMR Shareholding
21st Dec 201212:18 pmRNSDirector/PDMR Shareholding
21st Dec 201211:48 amRNSResult of EGM
18th Dec 20127:00 amRNSYear End Update
5th Dec 201211:37 amRNSDirector/PDMR Shareholding
30th Nov 20123:27 pmRNSMiscellaneous re SkyePharma (Jersey) Ltd
29th Nov 20129:34 amRNSHolding(s) in Company
28th Nov 20125:36 pmRNSNotice of EGM
21st Nov 201210:05 amRNSHolding(s) in Company
6th Nov 20125:58 pmRNSHolding(s) in Company
6th Nov 20125:18 pmRNSDirector/PDMR Shareholding
15th Oct 20127:00 amRNSInterim Management Statement
5th Oct 20124:44 pmRNSHolding(s) in Company
4th Oct 20122:27 pmRNSHolding(s) in Company
3rd Oct 20125:35 pmRNSDirector/PDMR Shareholding
3rd Oct 20124:40 pmRNSSecond Price Monitoring Extn
3rd Oct 20124:35 pmRNSPrice Monitoring Extension
28th Sep 201210:57 amRNSHolding(s) in Company
28th Sep 20127:00 amRNSAmendment to CRC Finance Facility
27th Sep 20124:33 pmRNSHolding(s) in Company
27th Sep 20129:28 amRNSHolding(s) in Company
26th Sep 20123:48 pmRNSHolding(s) in Company
26th Sep 20122:51 pmRNSHolding(s) in Company
26th Sep 201211:48 amRNSHolding(s) in Company
26th Sep 201211:19 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.